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Stroke is the fourth leading cause of death worldwide. It is caused by 
a blood clot or a ruptured artery in the brain. Following stroke onset, 
70%-88% of patients have motor dysfunction. Rehabilitation 
programs aim to combat this motor deficit through repetitive tasks 
designed to guide the brain to adapt to new movements and gain 
muscle memory in those movements. Rehabilitation is strongly 
dependent on the brain’s plasticity, which is enacted through 
increased levels of brain-derived neurotrophic factor (BDNF). 
BDNF has been proven to be increased through aerobic exercise, a 
common element found in rehabilitation programs. Memantine, an 
Alzheimer’s drug tested in rats regarding motor function, is a viable 
drug to increase plasticity. In several rat models, Memantine was 
proven to increase cognitive function and BDNF levels in the brain, 
which is vital for the recovery of stroke patients. However, the drug 
is still only used to treat Alzheimer’s patients. So, by understanding 
the relationship between time, exercise, plasticity, and recovery, 
Memantine can be introduced and implemented  in recovery 
programs for stroke patients. 
Objectives
The two main objectives of this study are:
1. To understand the relationship between factors such as time, 
exercise, and plasticity to refine existing rehabilitation 
treatments for recovering stroke patients 
2. To introduce Memantine, a drug commonly used for 
Alzheimer's disease, as a new addition to stroke rehabilitation 
programs 
Methods
A compilation of expert opinions on stroke recovery, rehabilitation 
programs, brain plasticity, and neuronal regrowth was examined, in 
addition to analyses of case studies relating factors such as time, 
and physical activity to neuronal regrowth and adaptation. The 
literature analyzed includes studies from the Journal of 
Neuroscience, Journal of American Medical Association, and the 
Journal of the American Physical Therapy Association . 
Results
• Previous studies have proven that rehabilitation procedures increase cellular proliferation and 
dendritic growth. With the cellular proliferation comes the creation of new neurons and neuronal 
pathways. The new neurons allow the brain to be plastic and adapt to new environments and thus 
allow recovering patients to regain their lost motor functions and fix their motor impairment. 
• The key to neurorehabilitation of the brain after a stroke is repetitive tasks that are similar to the 
patient’s everyday movements. The tasks are designed in this method so that patients can 
concentrate and gain practice in the movements that are most important in their day-to-day life. 
The application of their rehabilitation training with practical tasks creates stronger muscle 
memory than if the training was done by itself. 
Rehabilitation	  Programs
Time
• The length of time in which the brain is plastic differs slightly for every patient. However, there 
is an average period of time known as the critical period in which the adult brain’s plasticity is at 
its highest.
• Certain studies state that the stroke recovery is at its highest in the first six-ten weeks after stroke 
onset. Others argue that programs started within the first 100 days produces the same results no 
matter when the patient began rehabilitation within the 100-day period.
• But, there is a consensus on the fact that the brain has a critical period within which treatment 
must be completed.
Physical	  Activity
• BDNF belongs to a family group of proteins that is responsible for neuroprotection, 
neurogenesis, and neuroplasticity. It has been noted as a key mediator for motor learning and 
rehabilitation after a stroke occurrence, and is essential for long term memory, learning, and 
memory formation. 
• Physical activity has a positive effect on the brain regarding plasticity and cognitive functions. 
The manner in which aerobic exercise affects BDNF production is by indirectly altering 
molecular signaling pathways that act directly on the central nervous system, specifically, in the 
hippocampus, cerebellum, cerebral cortex, and spinal cord. 
• To affect BDNF levels, aerobic exercise sessions should be more than 30 minutes at a maximum 
of 70% heart rate, four times a week, and there must be a combination of aerobic and resistance 
exercises 
• In addition, the exercise must be done in close proximity with a rehabilitation task frequently in 
order to make the changes more permanent and effective. 
Combination	  Treatments
• Since neurological diseases and conditions have common factors underlying their symptoms and 
outcomes, combination therapies including exercise and drugs that affect growth factors for 
compounds such as BDNF provide a more successful recovery for patients
• Memantine has the capacity to improve and restore the levels of neurotrophins that affect motor 
functions, lower deficits and increase cognitive ability, while also increasing the synaptic 
plasticity of the brain.
Conclusions
• The checklist for the best chance of higher BDNF levels is a relatively simple list to complete. 
The tasks are simply aerobic exercise at a 70% heart rate for four days a week. By following this 
list, patients have higher BDNF levels. However, patients are not always capable of meeting 
these requirements due to emotional, mental, or physical capacity or ability. Without these 
requirements, their brain plasticity levels would not be high enough to train the brain to learn 
new skills. 
• To counteract this, Memantine can be administered to the patient to increase their BDNF levels 
in order to promote plasticity and kick-start rehabilitation training. Memantine can be used as an 
alternative to the exercise prior to rehabilitation tasks, or if needed, in conjunction with the 
exercise. 
• Patients that are able to perform some of the aerobic exercise can use Memantine as a booster to 
increase their BDNF levels to an adequate amount. Patients that are incapable of performing any 
exercise may take Memantine as an alternative treatment prior to their rehabilitation training. 
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Memantine
• In a beam crossing test, Memantine decreased the time it took for the rat to cross the beam when 
compared with the control group. 
• In the same study, Memantine also increased the time during which the rats could hang on to a 
rod in the horizontal grid test when compared to the control group. 
• In a grid walking test, the number of foot faults out of total steps was measured in a non-
Memantine group of rats, and Memantine injected group of rats. The results showed that the 
Memantine injected group of rats had a lower number of foot faults out of total steps taken. 
Further	  Studies
Before Memantine can be administered as an official treatment, further studies must be conducted 
regarding:
1. The critical period following stroke onset to better understand the relationship between time and 
brain plasticity 
2. Physical activity and Memantine to establish a baseline combination therapy for the average 
stroke patient 
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